A catalogue of verified and characterized arterial enhancers for key arterial identity genes
Preprint
Nornes S. et al, (2024)
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response.
Journal article
Zhang P. et al, (2021), Cancer Res
ETS factors are required but not sufficient for specific patterns of enhancer activity in different endothelial subtypes.
Journal article
Neal A. et al, (2021), Dev Biol, 473, 1 - 14